AMGN · 8-K · 20260804PR000124
Capital Expenditure Outlook
AMGEN INC · 2026-08-04 · Importance 75 · Surprise 64 · In source text
Amgen reported capital expenditures of $1.225 billion for the six months ended June 30, 2026, compared with $780 million in the prior-year period, an increase of approximately 57%. Second-quarter capital expenditures were $513 million, up from $369 million in the second quarter of 2025. Six-month free cash flow increased to $4.966 billion from $2.891 billion, indicating that the higher investment level was supported by operating cash generation.
Key facts
- For the full year 2026, capital expenditures are expected to be approximately $2.6 billion. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | committed | — | For the full year 2026, capital expenditures are expected to be approximately $2.6 billion. |
| assets | positive | committed | — | For the full year 2026, capital expenditures are expected to be approximately $2.6 billion. |